UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 25, 2021
Accession Number:
0001654954-21-001894
Submission Type:
POS AM
CIK:
0001378624
Company Name:
Cellular Biomedicine Group, Inc.
File Number:
333-227773